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Drug resistance of Pseudomonas aeruginosa is a leading problem in hospital infections. The aim of this study was to 
determine the best molecular genetic discrimination method for Pseudomonas spp. isolates among 94 outpatients and 
inpatients and see their grouping by phenotype characteristics (biofilm formation, frequency of serotypes, pigmentation, 
production of different class of beta-lactamases, and susceptibility to different antibiotic classes) and genotype. The most 
common serotypes were P1, P6, and P11, while co-productions of pyoverdine and pyocyanin were observed in 70 % of 
isolates. A total of 77.66 % isolates were mostly weak and moderate biofilm producers. Isolates were susceptible to colistin 
(100 %), aztreonam (97.87 %), imipenem (91.49 %), doripenem (90.43 %), and meropenem (84.04 %). MICs values 
confirmed susceptibility to ceftazidime and cefepime and singled out meripenem as the most effective inhibitor. Most 
isolates were resistant to aminoglycosides and fluoroquinolones. Only two isolates produced ESBL, eight were 
carbapenemase producers, and five isolates produced MBLs. Twenty-nine isolates were multidrug-resistant; 82.8 % of 
which produced both pigments, 58.3 % were non-typeable, while the P6 and P11 serotypes were equally distributed 
(16.7 %). Thirteen MDR isolates were strong enzyme producers. RAPD PCR analysis using primer 272 proved the best 
at discriminatory fingerprinting for Pseudomonas isolates, as it allocated 12 clusters. A correlation between DNA patterns 
and antibiotic resistance, production of pigments, serotypes distribution, and biofilm formation was not observed, and 
only confirmed higher genetic heterogeneity among P. aeruginosa isolates, which suggests that other molecular methods 
are needed to reveal potential relations between genotypic patterns and phenotypic characteristics.
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Pseudomonas aeruginosa has cosmopolitan distribution 
and can easily survive in moist environments. It is used in 
the production of various pigments such as pyocyanin (blue 
and green), pyoverdine (yellow-green fluorescent pigment), 
pyorubin (dark red), and pyomelanin (brown). It also makes 
normal part of the human microbiota of the skin (0–2 %), 
nasal mucosa (0–3.3 %), larynx (0–6.6 %), and colon 
(10 %), while in faecal samples it can range from 2.6 to 
24 % (1). It can be found in 5 % of saliva and 80 % of burns 
and wounds in hospitalised patients (2) and is one of the 
leading causes of hospital infections, as it easily colonises 
the skin and mucous membrane and most often causes 
infection in immunocompromised patients. In the world it 
causes between 11 and 13.8 % of all hospital infections (3), 
and Serbia with its 13.3 % is no different (4) and has high 
mortality rates due to weakened host immune response, 
high virulence, and high toxicity of its enzymes and toxins.
In addition, it has developed high resistance to many 
antibiotic classes (4, 5) through its defence mechanisms, 
which involve reducing antibiotic concentration in the cell, 
changing the target site, and antibiotic inactivation by its 
own or acquired enzymes. Multidrug resistance (MDR) of 
P. aeruginosa is defined as non-susceptibility to at least one 
type of antibiotic from three or more classes of 
antipseudomonal antibiotics (5). This MDR to different 
groups or even all antibiotics is owed to a large number of 
mutations, horizontal gene transfers, and increased efflux, 
which limits treatment choices to aminoglycosides and 
imipenem as intravenous antibiotics (6, 7). Treatment 
options may further be limited to colistin (aka polymyxin 
E) alone (8), if the cell membrane loses porins (OprD) and 
is less permeable to aminoglycosides or if P. aeruginosa 
produces metallo-beta-lactamases (MBLs), which 
hydrolyse all beta-lactams except aztreonam, and certain 
extended-spectrum beta-lactamase (ESBLs), which modify 
aminoglycosides (7, 9). Six such MBL enzyme types (VIM, 
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IMP, SPM, GIM, AIM, and, NDM), have been identified 
in clinical P. aeruginosa isolates in Serbia (6).
Biofilm formation is a complex process that begins with 
the binding of bacteria to the surface, after which they 
multiply, aggregate and form multilayer deposits, which 
could serve as a reservoir for the spreading of living cells 
and cause the development of chronic infections. P. 
aeruginosa has a natural tendency to bind to wet surfaces 
and form a biofilm from exopolysaccharides (EPS), nucleic 
acids, lipids, and ions (10), and – as such bacteria dominate 
the wound infections – postpone or prevent wound healing 
and diminish antibiotic activity (11). Prevention of biofilm 
formation in infections is crucial, because resistance to 
antibiotic increases 10–1,000 times, and P. aeruginosa in 
biofilm is more pathogenic than in the planktonic form (12).
Since P. aeruginosa is a major cause of hospital 
infections, identifying its antigen serotypes and biofilm 
formation ability is highly important for its epidemiological 
subtyping (13). However, methods such as protein profiling 
and pulsed-field gel electrophoresis (PFGE), which are used 
as gold standards for molecular discrimination of isolates, 
are often limited in their separation ability of Pseudomonas 
spp. genotypes and require additional expensive and time-
consuming species-specific profiling methods (14). 
Consequently, they are replaced by various polymerase 
chain reaction (PCR) techniques, such as random 
amplification of polymorphic DNA (RAPD) and repetitive 
element sequence-based PCR (rep-PCR). These ensure 
reliable grouping of the same bacterial strains in 
corresponding clusters and ultimately simplify isolate 
selection for further identification (15). DNA fingerprinting 
is simple, inexpensive, quickly discriminates bacterial 
isolates, and is reliable for classification and typing of a 
wide range of Gram-negative bacteria (15).
The aim of our study was to determine the frequency 
of multidrug-resistant P. aeruginosa subtypes among 
outpatient and inpatient isolates from the south of Serbia 
and see how their phenotypic characteristics (susceptibility 
to different antibiotic classes, the expression of different 
class of beta-lactamases, frequency of serotypes, production 
of pigments, and biofilm formation) relate to their genotypic 




Between 2013 and 2015, we collected 94 bacterial 
isolates, initially characterised as Pseudomonas spp., from 
the urine, sputum, and wound, throat, tongue, ear, and 
vaginal swabs of in and outpatients treated at the Clinical 
Hospital Centre Aleksinac.
The obtained samples were inoculated within a few 
hours on the following substrates: Columbia blood agar 
base, MacConkey agar, endo agar, tryptone soy agar, 
Mueller-Hinton agar (MHA), glucose, and thioglycollate 
broths (all purchased from Oxoid Ltd., Basingstoke, UK). 
Luria-Bertani (LB) medium and cetrimide agar (Lab M 
Limited, Bury, UK) were used for further testing. All 
isolates were grown overnight at 37 °C, stocked in 30 % 
glycerol, and stored at -80 °C until further use.
Ethical approval
The use of clinical strains was approved by the hospital’s 
ethics committee (decision No. 3242). Patient-identifiable 
information was coded and hidden from us and we had no 
contact with patients who gave the samples, so no informed 
consent was necessary for this study. None of the clinical 
data previously obtained were associated with the isolates 
of this study.
Serotyping
Pseudomonas spp. isolates were serotyped with the slide 
agglutination test according to the manufacturer’s 
instructions (Bio-Rad, Marnes-la-Coquette, France). The 
test set contained four polyvalent (PMA, PMF, PME, and 
PMC) and 16 monovalent serotypes (P1, P3, P4, and P6 
from the PMA group; P7, P8, P11, and P12 from the PMF 
group; P2, P5, P15, and P16 from the PME group; and P9, 
P10, P13, and P14 from the PMC group). Agglutination 
was positive only if clear within two minutes. The isolates 
were scored as polyagglutinable, monoagglutinable, or 
non-typeable.
Pigmentation
Pigment production of Pseudomonas spp. isolates was 
tested on specialised media: pyocyanin (blue pigment) and/
or pyomelanin (brown pigment) on the King agar A and 
pyoverdine (yellow-green pigment) on Pseudomonas 
fluorescein agar (all from HiMedia, Mumbai, India).
Biofilm formation
Biofilm formation was quantified with a modified 
version of the method described by Stepanović et al. (16). 
Each isolate was tested in triplicate (in three wells of 96-
well microtiter plate), and all tests were carried in three 
separate experiments during three consecutive days. The 
wells of a 96-well flat-bottomed microplate were filled with 
a final volume of 200 µL [180 µL of Mueller-Hinton broth 
(MHB) and 20 µL of bacteria (5×105 CFU/mL)]. Negative 
control wells contained MHB only. After incubation at 
35 °C for 24 h, the plates were decanted and the wells 
washed three times with 300 µL of phosphate buffer 
(1×PBS, pH 7.2, 25 °C). The remaining attached bacteria 
were fixed with 150 µL of methanol per well, and the plates 
emptied after 20 min and left to air dry. The final step was 
staining with 150 µL of 2 % Crystal Violet (Lach-Ner, 
Neratovice, Czech Republic) per well for 15 min. Excessive 
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stain was rinsed off with running tap water. After air drying, 
the remaining stain was solved with 150 µL of 96 % ethanol 
per well. Forty-eight hours later, we measured biofilm 
optical density (OD) of each strain with an automated 
Multiskan FC reader (Flow Titertek Multiskan Plus, Flow 
Laboratories Co., Turku, Finland) at 570 nm. The obtained 
readings served to set the OD cut-off values (ODc) (three 
standard deviations above the average mean OD of negative 
control) as described elsewhere (16). Each strain was 
classified into one of the following categories: not a biofilm 
producer (OD≤ODc, category 0 or -); weak biofilm producer 
(OD≤ODc≤2×ODc, category 1 or +), moderate biofilm 
producer (2×ODc≤OD≤4×ODc, category 2 or ++), or strong 
biofilm producer (4×ODc≤OD, category 3 or +++).
Disk diffusion method
Antimicrobial susceptibility of the isolates was tested 
with the disk diffusion method following the protocol 
described by the Clinical and Laboratory Standards Institute 
(17). For this purpose we used standardised single antibiotic 
discs (Rosco Diagnostica, Taastrup, Denmark) at the 
following concentrations (μg per disc): 5 µg for ofloxacin, 
ciprofloxacin, and levofloxacin; 10 µg for piperacillin/
tazobactam, imipenem, doripenem, meropenem, colistin, 
aztreonam, gentamicin, and tobramycin; and 30 µg for 
ceftazidime, cefepime, netilmicin, and amikacin. Readings 
were taken after incubation at 37 °C for 24 h and expressed 
in mm. The isolates were classified as susceptible (S), 
intermediate (I) or resistant (R).
Minimum inhibitory concentration assay
The sensitivity of our Pseudomonas spp. isolates to 
antibiotics was determined with a broth microdilution test 
in 96-well microtitre plates according to the protocol of the 
European Committee for Antimicrobial Susceptibility 
Testing (18) and the ISO 20776-1:2006 (19) standard. 
Clinical isolates were suspended in a saline solution and 
adjusted to turbidity of 0.5 per McFarland standard (Bio-
Merieux, France), which corresponds to 1.0×108 CFU/mL. 
Antibiotics ceftazidime, cefepime, and meropenem (Sigma-
Aldrich, St. Louis, MO, USA) were first dissolved in 
purified sterile water at stock concentration of 1000 µg/mL 
and then serially diluted in MHB in the following 
concentrations: 1–32 µg/mL (for ceftazidime and cefepime) 
and 1–16 µg/mL (for meropenem). Besides negative 
control, sterility control was also tested. All dilutions of 
antibiotics were done in triplicate, and the experiment was 
repeated twice over two consecutive days. Each well, except 
for the sterility control, was inoculated with 20 µL of 
bacterial culture (5×105 CFU/mL), reaching the final volume 
of 200 µL. Ten µL of 2,3,5-triphenyltetrazolium chloride 
(TTC, Sigma-Aldrich) was added to MHB. TTC is a 
colourless redox indicator that is enzymatically reduced 
with cellular dehydrogenase to a red metabolite 
2,3,5-triphenyltetrazolium formazan if the cells are live, 
and metabolically active. The plates were incubated 
aerobically at 37 °C for 20 h. The lowest antibiotic 
concentration which yielded no change of colour was 
defined as the minimum inhibitory concentration (MIC). 
The results are expressed in µg/mL.
Identification of beta-lactamase-producing isolates
Extended spectrum beta-lactamase (ESBL)
The production of ESBLs was detected with the double-
disk synergy test (DDST) and confirmed with the 
combination disk test (CDT) (20). For DDST, the discs of 
amoxicillin/clavulanic acid (AMC, 20/10 µg), cephalexin 
(CL, 30 µg), and cefotaxime (CTX, 30 µg) were placed on 
plates inoculated with Pseudomonas spp. isolates at the 
optimal distance of 17 mm. After an overnight aerobic 
incubation at 37 °C, the isolate was considered ESBL-
positive if zones of inhibition spread toward the disc with 
beta-lactamase inhibitor (AMC) or any additional inhibition 
zone was observed. If the strain did not produce beta-
lactamase, however, such characteristic changes on the plate 
were not observed. In case of a positive test, a confirmative 
CDT test was carried out by placing ceftazidime/clavulanic 
acid (30/10 µg) and ceftazidime (30 µg) discs. ESBL 
production was confirmed if the difference in the zones of 
inhibition around the discs with and without ESBL inhibitor 
were 5 mm or more.
Carbapenemases
Carbapenemase production was tested with a modified 
Hodge test (21). An overnight culture of E. coli ATCC 25922 
(turbidity adjusted to 0.5 per McFarland standard) was 
inoculated on the surface of an MHA plate. A meropenem 
disk (10 µg) was placed at the centre of the plate, and 
isolates of Pseudomonas spp. were placed around the disc 
in radial stripes (extending from the edge of the disc to the 
periphery of the plate). The plates were incubated at 37 °C 
overnight. The test was positive if a clover leaf-like 
indentation was formed in the meropenem inhibition along 
the streaks of the tested isolate.
Metallo-beta-lactamase (MBL)
The isolates were tested for MBL production with the 
EDTA synergy test as described elsewhere (22). Briefly, an 
overnight liquid culture of the tested isolate (turbidity 
adjusted to 0.5 per McFarland standard) was spread on the 
surface of the MHA plate. Two imipenem discs (10 µg) 
were placed on the agar 15 mm apart and 10 µL of 0.5 EDTA 
was pipetted on one of the imipenem discs. After an 
overnight incubation at 37 °C, the expanded inhibition zone 
between the two discs or expansion of more than 6 mm in 
the imipenem/EDTA disc were interpreted as positive for 
MBL production.
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PCR-based DNA amplifications
Genomic DNA (gDNA) was isolated from the 
Pseudomonas spp. following the method described by 
Janakiev et al. (23). The BOX (CTACGGCAAGGCGACG 
CTGACG), ERIC-1R (CACTTAGGGGTCCTGAATGTA), 
ERIC-2 (AAGTAAGTGACTGGGGTGAGCG), 272 
(AGCGGGCCAA), and 208 (ACGGCCGACC) primers 
were rep-PCR and RAPD PCR fingerprinted (24, 25) and 
amplified (each in the final concentration of 10 μmol/L) in 
a 25 µL reaction mixture containing 1 µL of template DNA, 
1.5 µL of 25 mmol/L MgCl2 (KAPA Biosystems, Wilmington, 
MA, USA), 2.5 µL of 10 mmol/L 10×KAPA Taq buffer, 
0.5 µL of 10 mmol/L dNTP (KAPA Biosystems), and 0.1 µL 
of KAPA Taq polymerase (KAPA Biosystems).
The ERIC and BOX PCR reactions were done in the 
following steps: initial denaturation at 95 °C for 7 min, 30 
cycles of denaturation at 94 °C for 1 min, primer annealing 
46 °C for 1 min, and polymerisation at 65 °C for 8 min. For 
the 272 primer the steps were as follows: initial denaturation 
at 94 °C for 2 min, 35 cycles of denaturation at 94 °C for 
30 s; primer annealing at 35 °C for 30 s, and polymerisation 
at a 72 °C for 2 min. The steps for the 208 primer were: 
four cycles of auto-extension (each consisting of initial 
denaturation at 94 °C for 5 min, primer annealing at 36 °C 
for 5 min, and polymerisation at 72 °C for 5 min), 30 cycles 
of denaturation at 94 °C for 1 min; primer annealing at 
36 °C for 1 min, and polymerisation at 72 °C for 2 min. 
The final extension step for BOX and ERIC was done at 
65 °C for 16 min and for 208 and 272 primers at 72 °C for 
10 min.
From the obtained DNA fingerprints we built a 
dendrogram using the PyElph 1.4 software (26) and then 
determined clustering patterns using the unweighted pair 
group method with arithmetic mean (UPGMA) algorithm 
with a bootstrap value of 100. The position of pattern strips 
was checked manually.
The total DNA of selected isolates was used for 16S 
rRNA PCR amplification and isolate identification with 
universal primers UN116sF (GAGAGTTTGATCCTGGC) 
and UN116sR (AGGAGGTGATCCAGCCG). The reaction 
mixture was prepared as described above, and the conditions 
were the usual ones for primer annealing at 50 ºC for 1 min. 
The amplicons were purified on a QIAquick Gel Extraction 
KIT/250 column (QIAGEN GmbH, Hilden, Germany) and 
sequenced commercially (Macrogen, Amsterdam, 
Netherlands). The obtained sequences were searched for 
homology at the National Center for Biotechnology 
Information using the Basic Logical Alignment Search Tool, 
aligned with the ClustalW multiple sequence alignment in 
program BioEdit 7.1.3 (Tom Hall, North Carolina State 
University, Raleigh, NC, USA) and checked manually. The 
phylogenetic tree was constructed with the MEGA 7.0 
software (Pennsylvania State University, Philadelphia, PA, 
USA) using the neighbour-joining method based on a 
pairwise distance matrix obtained with the Kimura two-
parameter nucleotide substitution model. The topology of 
the trees was evaluated with the bootstrap resampling 
method with 1000 replicates.
Statistical analysis
The data obtained in this study were analysed with 
descriptive statistics using IBM SPSS Statistics for 
Windows, version 25.0 (IBM Corp., Armonk, NY, USA).
RESULTS AND DISCUSSION
Isolate origins
Of the 94 Pseudomonas spp. isolates 44 were identified 
in outpatients and 50 in inpatients. The predominant number 
of isolates came from wound swabs (46.8 %) of inpatients 
only. The majority of other isolates originated from urine 
samples (21.3 %) and throat swabs (13.8 %), mostly from 
outpatients. Isolates from sputum samples (9.6 %), ear 
(4.3 %), tongue (2.1 %), and vaginal swabs (2.1 %) were 
rare. We already reported about their high prevalence in 
urine (36.79 %) and wounds (29 %) nearly ten years ago 
(27).
Isolate serotypes, pigmentation, and biofilm formation
Table 1 shows our findings in terms of isolate serotypes, 
pigmentation, and biofilm formation. Twenty-eight isolates 
were non-typeable. All of the remaining identified serotypes 
were from polyvalent groups (PMA, PME, PMC, and PMF). 
Most belonged to the PMA and PMF groups, which included 
the P1 and P6 serotypes. The PMC group included the P9 
and P10, while the PME and PMF groups P5 and P11 
serotypes, respectively. The most commonly identified 
monovalent serotypes were P1 (17.02 %), P6 (22.34 %), 
and P11 (15.96 %). Co-production of pyoverdine and 
pyocyanin was observed in 70 % of clinical isolates, while 
the production of only pyoverdine in 22.3 % and of 
pyocyanin in 7.4 % of the isolates. Most isolates (77.66 %) 
expressed some biofilm formation ability, mostly weak 
(53.42 %, most of them originating from inpatient wounds 
and outpatient urine cultures) and moderate (39.73 %, most 
of them originating from inpatient wounds), while only five 
isolates were strong biofilm producers.
These findings are consistent with earlier reports 
showing dominance of the P3, P6, and P11 serotypes (28, 
29, 30) and pigmentation where the synthesis of pyoverdine 
(79.75 %) was more pronounced than the synthesis of 
pyocyanin (44.14 %) (27). The pigments of the clinical 
Pseudomonas spp. isolates participate in the development 
and maintenance of tissue lesions under inflammation in 
different ways. Therefore, the production of pigment is not 
only a phenotype characteristic but also an indicator of the 
level of pathogenicity of individual strains (27). However, 
a similar study in Serbia reported that only 2.45 % of 163 
clinical P. aeruginosa isolates did not form a biofilm. 
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34.36 % were moderate, and most (39.26 %) were strong 
biofilm producers (31). Usually, biofilm forming is strong 
in invasive infections associated with the application of 
medical devices (such as urinary and central venous 
catheters or tracheostomy and endotracheal tubes) or with 
chronic pulmonary diseases like cystic fibrosis and chronic 
obstructive bronchitis, where bacteria firmly adhere to the 
plastic surface or viscous mucus. In our study, however, the 
isolates were collected from less invasive and/or superficial 
infections, which may explain weak to moderate biofilm 
formation. Similarly weak to moderate biofilm formation 
was reported by da Costa Lima et al. (32), whereas 
Nasirmoghadas et al. (33) evidenced that isolates may 
significantly differ in their ability to form biofilm even in 
the same type of infection. They reported that between 
multidrug-resistant and extended drug-resistant strains of 
P. aeruginosa isolated from patient burns, most of the 
isolates were weak (67 %) or moderate (22 %) biofilm 
producers.
Antibiotic susceptibility and enzyme production
Susceptibility to 15 antibiotics from different classes 
such as aminoglycosides (amikacin, gentamicin, netilmicin 
and tobramycin), fluoroquinolones (ofloxacin, ciprofloxacin 
and levofloxacin), polypeptides (colistin), penicillin 
combination (piperacillin/tazobactam), monobactams 
(aztreonam), cephalosporins (ceftazidime and cefepime), 
and carbapenems (doripenem, imipenem and meropenem) 
was tested in all isolates. Figure 1 shows that all isolates 
were sensitive to colistin, and most to aztreonam (97.87 %), 
imipenem, and doripenem (91.49 % and 90.43 %, 
respectively), while 84.04 % of the isolates were susceptible 
to meropenem and the piperacillin/tazobactam combination. 
These findings single out colistin as antibiotic of choice, 
but only as a last resort due to its neurotoxicity (34).
Regarding ceftazidime and cefepime susceptibility, 
70.21 % and 75.53 % of the isolates were sensitive to 3rd 
and 4th generation cephalosporins, respectively. The highest 
number of resistant isolates was observed in testing with 
aminoglycoside [gentamicin (39.36 %), netilmicin 
(35.10 %) and tobramycin (37.23 %)], and fluoroquinolone 
[ofloxacin (38.30 %), ciprofloxacin (34.04 %) and 
levofloxacin (32.98 %)] classes. Twenty-three of inpatient 
isolates were resistant to fluoroquinolone ofloxacin (46 %) 
and seventeen of outpatient isolates to aminoglycoside 
gentamicin (38.64 %). Cefepime best inhibited Pseudomonas 
inpatient isolates, and ceftazidime outpatient isolates (Table 
2).
MICs for ceftazidime, cefepime, and meropenem 
confirmed these findings and singled out meripenem as the 
most effective inhibitor, as 72 isolates (76.6 %) were highly 
susceptible to meropenem with MIC below 1 µg/mL (Table 
3). The most resistant isolates were obtained from wounds, 
urine, and sputum.
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Only two isolates – one from inpatient wound and the 
other from outpatient urine – produced ESBL, which is the 
likely reason for resistance to piperacillin/tazobactam, 
cephalosporins, and aztreonam (Tables 2 and 3). Eight 
isolates – five wound and three urine – produced 
carbapenemases. All of these inpatient wound isolates were 
resistant to carbapenems, and all isolates showed multidrug 
resistance, except 10800 (Table 2). Five isolates produced 
MBLs (three from inpatient wounds and two from outpatient 
ear and urine specimens) (Table 3). Two wound isolates 
were resistant to the piperacillin/tazobactam combination, 
while all isolates were susceptible to doripenem (Table 2).
Inpatient isolates generally showed much stronger 
resistance than outpatient, which is in line with earlier 
reports (35). Similar was also the prevalence of 
aminoglycoside-resistant P. aeruginosa isolates (around 
30 %) reported earlier for tobramycin and amikacin (36, 
37). In contrast, a group of Bulgarian scientists (38) reported 
more than two times higher resistance to gentamicin (79.7 
%) and netilmicin (69.6 %) than we have. It is encouraging, 
though, that susceptibility to colistin, meropenem, and 
imipenem has not dropped in Serbia over the last five years, 
judging by a 2015 report (4). However, resistance to 
fluoroquinolones seems to have increased, most likely as a 
consequence of enhanced antibiotic extrusion through efflux 
pump as reported before (39). Also, frequent use of 
ceftazidime and cefepime has resulted in associated 
resistance and limited use (40). A different rate of resistance 
to ceftazidime has been reported across Europe, including 
patients from Lithuania (13.9 %), Italy (13.4 %), Spain 
(15 %), Greece (25.5 %) and Belgium (28.5 %) (41). Lutz 
et al. (42) reported resistance to ceftazidime and meropenem 
of 14.1 % and 9.4 %, respectively, which proved meropenem 
to be the best antibiotic, as we have. The difference in the 
resistance to ceftazidime and cefepime was not significant 
in many studies. Most often it was attributed to intrinsic 
resistance that Pseudomonas isolates naturally possess, 
usually utilising enzymes to destroy the drug. Another 
reason is the MexCD-OprJ efflux system, which is selective 
for the 4th generation of cephalosporins (43). Extended-
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Figure 1 Susceptibility of clinical isolates of Pseudomonas spp. on different antibiotic classes. The isolates were classified as resistant 
(R), intermediate (I), or susceptible (S)
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spectrum beta-lactamases are responsible for the hydrolysis 
of most penicillins, extended-spectrum cephalosporins, and 
aztreonam and their production also differs in some parts 
of the world (44). In Western Europe, the production of 
ESBL does not exceed 1 %, while it is much larger in China 
and other parts of the world (7), which was not the case in 
our study. The use of carbapenems, as the only choice 
against ESBL-producing isolates, leads to an increased 
resistance to antibiotics from the 4th generation of 
cephalosporins. Thus, the detection of carbapenemase is of 
great importance for proper therapy administration as well 
as infection control. Although discovered relatively early, 
carbapenemases are a major problem in the world, since 
their encoding genes, mostly found on transmissible genetic 
elements, are associated with other resistance genes, which 
leads to uncontrolled spread of resistance (45). The 
occurrence of metallo-beta-lactamase-producing isolates 
in hospitals and their spreading among bacteria is a serious 
problem for future therapy. Low prevalence of MBL 
producing P. aeruginosa isolates was reported in the 
countries of the Balkan region, but these strains belonged 
to the epidemic clones spread all over the Mediterranean 
Europe (7). In addition, Serbia and the entire Balkan region 
confirmed the presence of the New Delhi MBL 1 (NDM-1) 
in P. aeruginosa clinical isolates for the first time nearly a 
decade ago (6).
Relationship between antibiotic resistance/susceptibility 
and phenotypic characteristics of clinical isolates
Table 4 shows that 29 (18 inpatient and 11 outpatient) 
of our 94 isolates were resistant to up to three or more 
antibiotic classes. Fourteen originated from wounds 
(48.3 %) and 12 from urine (41.4 %), while only a few came 
from sputum and tongue. Twenty-four MDR isolates 
(82.8 %) produced both pyoverdine and pyocyanin (no other 
pigments were observed), all were non-typeable, while the 
P6 and P11 serotypes were equally distributed among all 
MDR isolates. Nine of the MDR isolates – mostly inpatient 
wound – were moderate biofilm producers, while 12 showed 
weak biofilm formation. Only one from inpatient urine 
formed a strong biofilm. As many as 13 MDR isolates 
(44.8 %) produced antibiotic-metabolising enzymes, while 
only two were in the group of isolates resistant to up to two 
antibiotic classes (Tables 3 and 4). Among these, only five 
(35.7 %) had the P6 serotype and produced moderate or 
weak biofilm and both pigments. Six isolates from the same 
group produced only pyoverdine and weak biofilm or none 
at all. In contrast, most isolates resistant to one antibiotic 
class were non-typeable (six isolates, 42.9 %) and had the 
P11 serotype (four isolates, 28.6 %). Most were moderate 
or strong biofilm- and pigment producers (Table 4). Thirty-
seven isolates (39.4 %) were completely susceptible to all 
tested antibiotic classes. P1 and P6 were the most common 
monovalent serotypes among them (27.7 % and 24.3 %, 
respectively), with weak or non-biofilm formation, while 
the production of both pigments was again predominant.
In general, no direct correlation was observed between 
antibiotic susceptibility and virulence-associated phenotypic 
characteristics, serotype distribution in particular. In studies 
described earlier, P6 and P11 were the most abundant 
serogroups in all types of P. aeruginosa-caused infections 
(46), while the P1 serotype isolates showed susceptibility 
to the majority of the tested antibiotics (47), which was in 
accordance with our results. Thrane et al. (48) showed that 
serotypes do not correlate to antibiotic resistance, as they 
switch through recombination and can mislead isolate 
antibiotic susceptibility classification. Similar lack of 
correlation between antibiotic resistance and pigment 
production has been established by Finlayson and Brown 
(49). There is, however, a correlation between biofilm 
formation and the pattern of antibiotic resistance/
susceptibility. Evidence by Corehtash et al. (50) that 
resistant isolates produce moderate or strong biofilm seems 
to corroborate our own findings.
Antibiotic resistance/susceptibility in relation to 
molecular genetic characterisation
Based on the results of pigmentation, serotyping, 
biofilm formation, enzyme production, and antibiotic 
resistance/susceptibility, a total of 45 isolates were selected 
{Table 4 [Group I – resistant to up to four antibiotic classes 
or more (groups 1-1 to 1-10); Group II – resistant to up to 
three antibiotic classes (groups 2-1 to 2-10); Group III – 
resistant to up to two antibiotic classes (groups 3-1 to 3-10); 
Group IV – resistant to one antibiotic class (groups 4-1 to 
4-10); and Group V – susceptible to all tested antibiotic 
classes (groups 5-1 to 5-5)]} for further rep-PCR and RAPD 
PCR molecular genetic analysis (Table 5) to see it genetic 
clusterisation of different isolates in relation to phenotypic 
characteristics.
Primers 272 and 208, which were used for the RAPD 
PCR, created 3 to 15 fingerprinting patterns, whose range 
differed from 100 bp to 5000 bp. These results show that 
different primers within the cluster with the largest number 
of isolates yield similar grouping (Figure 2). Primer 272 
allocated 12 clusters, while 208 allocated eight clusters. 
Extraordinary heterogeneity was noticed with both primers 
within the clusters. With primer 208 the largest cluster was 
extremely heterogeneous and included all but the fourth 
group of tested isolates was excluded. With primer 272, 
that same cluster was divided into as many as seven clusters. 
For both RAPD primers used, there was a noticeable pattern 
uniformity among different groups of antibiotic resistance. 
The case in point is pattern uniformity of the first, second, 
fourth, and fifth group. Similar uniformity was observed 
for isolate patterns of the third, first, and second group. In 
contrast, pattern dissimilarity (based on genetic distances) 
was observed between the isolates from the fourth and 
second group, especially with primer 272. The most 
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genetically distant and therefore most diverse patterns were 
obtained for the isolates from the susceptible group, in the 
form of separate monophyletic branch for isolates 5-1 
(primer 272) and 5-4 (primer 208).
Additionally, BOX and ERIC primers used in rep-PCR 
analysis created between five and 17 fingerprinting patterns 
of different sizes, ranging from 100 bp to 5000 bp. BOX 
PCR allocated a total of 10 clusters, indicating a good 
primer-discriminatory power, while ERIC PCR provided a 
total of eight clusters (Figure 3). As in RAPD analysis, the 
BOX PCR clusters were extremely heterogeneous, except 
for a few homogeneous clusters. The results of the BOX 
PCR analysis, like in RADP profiling, showed pattern 
uniformity of different antibiotic resistance groups, but 
certain clusters were heterogeneous. For instance, BOX 
PCR split the largest cluster obtained with primer 272 into 
four separate clusters. Pattern uniformity between isolates 
from the same resistance group within some clusters was 
also verified. The similarity between BOX and 272 primers 
was observed in terms of pattern uniformity between 
isolates from the first MDR group and those from the second 
and fourth group, as well as between the isolates from the 
fourth and fifth group. Another correlation was observed in 
pattern dissimilarity between isolates from the fourth and 
the second group, while isolate 5-1 was the most distant 
one genetically, as in BOX PCR analysis. ERIC PCR 
analysis generated more homogeneous isolate clustering 
from different antibiotic groups (mainly the second and the 
third group), and allocated a total of eight clusters. Unlike 
other tests, ERIC PCR showed pattern uniformity between 
the most susceptible isolates (the fifth group) and the 
second, third, and fourth group. Since RAPD272 PCR 
analysis provided the best characterisation with 12 clusters, 
we selected a few representative isolates from each cluster 
for 16S rRNA gene identification and all were identified as 
P. aeruginosa strains, which confirmed their genetic 
heterogeneity (Figure 4).
The use of 272 and 208 primers was successful in 
discrimination of different Pseudomonas isolates described 
before (28). Although Nagaveni et al. (51) showed that 
Figure 2 Dendrogram obtained by UPGMA analysis of the selected Pseudomonas isolates using 208 (top) and 272 (bottom) primers, 
based on RADP profile (right). Genetic distances were presented with numbers placed on the branches. Rectangles are representing 
the isolate grouping according to obtained RAPD patterns
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Table 4 Multidrug resistant Pseudomonas spp. isolates and their pigmentation, serotype, and biofilm formation potential
Isolate
coded name Origin Patient Pigment Serotype
Biofilm 
formation
2711 Urine Out Pyov, Pyoc P1 +
2597 Urine Out Pyov P6 +
3777 Urine Out Pyov, Pyoc P6 +
2124 Sputum Out Pyov, Pyoc P6 -
4188 Urine Out Pyov, Pyoc NT ++
7543 Wound In Pyov, Pyoc NT ++
2645 Wound In Pyov P5 ++
2900 Wound In Pyov, Pyoc NT ++
3451 Wound In Pyoc P11 ++
3714 Wound In Pyov, Pyoc NT +
3214 Urine Out Pyov, Pyoc NT -
8599 Urine Out Pyov, Pyoc P11 +
3322 Wound In Pyov P11 +
2073 Wound In Pyov, Pyoc P6 +
1087 Wound In Pyov, Pyoc P1 -
2581 Wound In Pyov, Pyoc NT -
1183 Urine In Pyov, Pyoc NT +
2638 Urine In Pyov, Pyoc NT +
2588 Urine Out Pyov, Pyoc P11 -
10019 Urine Out Pyov, Pyoc NT ++
2967 Tongue Out Pyov, Pyoc P6 ++
9921 Sputum Out Pyov, Pyoc P11 +
5797 Wound In Pyov, Pyoc NT -
4312 Wound In Pyov, Pyoc NT ++
5348 Wound In Pyov, Pyoc NT ++
3658 Wound In Pyov, Pyoc P11 -
2844 Urine In Pyov, Pyoc NT +++
3853 Urine In Pyov P1 +
5774 Wound In Pyov, Pyoc NT +
5518 Ear Out Pyov, Pyoc P6 ++
1408 Urine Out Pyov, Pyoc P9 +++
11838 Sputum Out Pyoc P9 +
2383 Tongue Out Pyov P10 -
8283 Wound In Pyov P11 +
10195 Wound In Pyov P6 +
3563 Wound In Pyov, Pyoc P6 ++
3122 Wound In Pyov NT +
10800 Wound In Pyov, Pyoc P6 +
2064 Wound In Pyov, Pyoc P1 ++
3199 Urine Out Pyov, Pyoc P6 +
10600 Urine Out Pyov P11 -
2875 Urine Out Pyov, Pyoc P1 +
8913 Wound In Pyov P9 -
2609 Ear Out Pyov P11 ++
4362 Urine Out Pyov, Pyoc P9 ++
1790 Urine Out Pyov, Pyoc P11 +
3496 Sputum Out Pyov, Pyoc P6 +++
8142 Sputum Out Pyov, Pyoc NT +++
2689 Vaginal swab Out Pyov NT ++
4211 Wound In Pyov, Pyoc NT ++
7881 Wound In Pyov, Pyoc P11 ++
971 Wound In Pyov, Pyoc NT +++
821 Wound In Pyoc P5 +
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Isolate
coded name Origin Patient Pigment Serotype
Biofilm 
formation
294 Sputum Out Pyov, Pyoc NT ++
7698 Wound In Pyov, Pyoc P9 +
1416 Wound In Pyov NT ++
10708 Wound In Pyov, Pyoc P11 +
3864 Throat Out Pyov, Pyoc P11 +
2047 Throat Out Pyov, Pyoc P1 ++
3238 Throat Out Pyov, Pyoc P6 -
11947 Wound In Pyov, Pyoc P1 +
6412 Wound In Pyov, Pyoc P9 ++
2966 Sputum Out Pyov, Pyoc P6 +
3540 Throat Out Pyov, Pyoc NT ++
2285 Urine Out Pyoc P1 +
2671 Vaginal swab Out Pyov, Pyoc NT -
2941 Sputum Out Pyov, Pyoc P6 -
3477 Throat Out Pyov, Pyoc P10 +
3919 Sputum Out Pyov, Pyoc P1 +
4087 Throat Out Pyov, Pyoc P1 +
4278 Ear Out Pyoc NT ++
4646 Throat Out Pyov, Pyoc P6 ++
5586 Urine Out Pyov, Pyoc NT +
7546 Ear Out Pyov, Pyoc P6 ++
9642 Throat Out Pyov, Pyoc P1 +
10412 Throat Out Pyov P6 -
1863 Throat Out Pyov, Pyoc NT +
2005 Throat Out Pyov P1 +
3883 Wound In Pyov, Pyoc NT -
4212 Wound In Pyov, Pyoc NT -
5661 Throat In Pyov, Pyoc P6 ++
611 Wound In Pyov, Pyoc P9 +
3595 Wound In Pyov, Pyoc P6 -
4071 Wound In Pyov, Pyoc P1 +
4082 Wound In Pyov P11 -
4314 Wound In Pyov, Pyoc P1 +
4354 Wound In Pyov, Pyoc P9 ++
4541 Wound In Pyov, Pyoc P9 ++
5660 Throat In Pyov, Pyoc NT ++
6982 Wound In Pyov, Pyoc P1 +
8702 Wound In Pyov, Pyoc P11 +
10336 Wound In Pyov, Pyoc P6 -
19677 Wound In Pyov P1 -
4473 Wound In Pyov, Pyoc P5 -
Pyov – Pyoverdine; Pyoc – Pyocyanin; NT – non-tippable; No biofilm producer (category -); Weak biofilm producer (category +); 
Moderate biofilm producer (category ++); Strong biofilm producer (category +++); Out – outpatient; In – inpatient; ■ Resistant up to 
four antibiotic classes or more; ■ Resistant up to three antibiotic classes; ■ Resistant up to two antibiotic classes; ■ Resistant up to one 
antibiotic class; ■ Susceptible to all tested antibiotic classes. Framed isolates have been selected for molecular genetic characterization
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Figure 3 Dendrogram obtained by UPGMA analysis of the selected Pseudomonas isolates using BOX (top) and ERIC (bottom) primers, 
based on rep-PCR profile (right). Genetic distances were presented with numbers placed on the branches. Rectangles are representing 
the isolate grouping according to obtained rep-PCR patterns
ERIC PCR provided an exceptionally qualitative 
discrimination for pseudomonads, the results of our and 
similar studies (52, 53), showed the advantage of BOX 
PCR, as it confirmed the results obtained with 272 RADP 
PCR.
We did not find a correlation between RAPD and rep-
PCR patterns and antibiotic resistance/susceptibility or 
other phenotype characteristics (production of pigments, 
distribution of serotypes and biofilm formation). The 
uniformity of genetic patterns of P. aeruginosa isolates in 
different antibiotic groups suggests that other molecular 
methods such as whole genome sequencing should also be 
used to find a correlation with other phenotype characteristics.
CONCLUSION
This is the first comprehensive study of genotype and 
phenotype characteristics of P. aeruginosa isolates from 
Southern Serbia. RAPD PCR analysis with the 272 primer 
proved to be the best discriminatory fingerprinting 
technique. Although we did not find any correlation between 
genotype patterns and phenotype characteristics (antibiotic 
resistance, pigmentation, serotypes, and biofilm formation), 
our findings call for other molecular combinations and a 
larger number of isolates to reveal potential connections 
between them.
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Table 5 Selected isolates for further molecular genetic analysis
Group I Group II Group III Group IV Group V
Resistant up to 4 
antibiotic classes or 
more
Resistant up to 3 
antibiotic classes
Resistant up to 2 
antibiotic classes
Resistant up to 1 
antibiotic class




























2711 1-1 5797 2-1 8283 3-1 2609 4-1 3864 5-1
7543 1-2 4312 2-2 5518 3-2 821 4-2 2047 5-2
2597 1-3 5348 2-3 10195 3-3 4362 4-3 6412 5-3
3714 1-4 10019 2-4 3563 3-4 1790 4-4 3238 5-4
2645 1-5 3658 2-5 3122 3-5 7881 4-5 11947 5-5
3777 1-6 2967 2-6 10800 3-6 4211 4-6
2900 1-7 2844 2-7 2064 3-7 3496 4-7
3451 1-8 3853 2-8 11838 3-8 8142 4-8
2124 1-9 2588 2-9 1408 3-9 971 4-9
4188 1-10 9921 2-10 2383 3-10 2689 4-10   
Figure 4 Phylogenetic relationships of Pseudomonas aeruginosa clinical isolates from all 12 RAPD272 clusters based on the sequence 
of 16S rRNA. Phylogenetic tree was constructed by the neighbour-joining method and the distances were calculated with the Kimura 
two-parameter model. Bootstrap values are given for each node, with 1000 replicates. Stenotrophomonas maltophilia was used as an 
outgroup. The horizontal bar indicates a genetic distance of 0.02
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Fenotipska i genetička obilježja osjetljivih i višestruko otpornih izolata Pseudomonas aeruginosa u južnoj Srbiji
Antibiotska rezistencija Pseudomonas aeruginosa vodeći je problem u bolničkim infekcijama. Cilj ovoga istraživanja 
bio je utvrditi najbolju diskriminatorno molekularno-genetičku metodu među 94 ambulantna i bolnička Pseudomonas 
spp. izolata kako bi se uvidjelo njihovo grupiranje u smislu različitih fenotipskih obilježja (stvaranje biofilma, učestalost 
serotipova, pigmentacija, proizvodnja različitih klasa beta-laktamaza i osjetljivost na različite skupine antibiotika) u 
skladu s genotipom. Najčešći serotipovi bili su P1, P6 i P11, a proizvodnja i pioverdina i piocijanina primijećena je kod 
70 % izolata. Ukupno 77,66 % izolata uglavnom je iskazalo slabu i umjerenu proizvodnju biofilma. Izolati su bili osjetljivi 
na kolistin (100 %), aztreonam (97,87 %), imipenem (91,49 %), doripenem (90,43 %) i meropenem (84,04 %). Vrijednosti 
MIC-ova potvrdile su podložnost izolata ceftazidimu i cefepimu, a izdvojile su meropenem kao najučinkovitiji inhibitor. 
Većina izolata bila je otporna na aminoglikozid i fluorokinolon. Samo dva izolata proizvela su ESBL, osam izolata 
sintetiziralo je karbapenemaze, a pet izolata imalo je sposobnost proizvodnje MBL-a. Dvadeset devet izolata bilo je 
višestruko rezistentno na antibiotike, od kojih je 82,8 % proizvodilo oba pigmenta, 58,3 % bili su netipabilni, a serotipovi 
P6 i P11 bili su podjednako zastupljeni među njima (16,7 %). Trinaest MDR izolata bili su snažni proizvođači enzima. 
RAPD PCR analiza korištenjem 272 početnica pokazala se kao najbolja diskriminatorna metoda otiskom prsta 
(fingerprinting) za Pseudomonas izolate, izdvajajući čak 12 različitih klastera. U ovom istraživanju nije zabilježena 
povezanost između DNA obrazaca i otpornosti na antibiotike, proizvodnje pigmenata, distribucije serotipova i stvaranja 
biofilma, što potvrđuje puno veću genetičku heterogenost unutar samih izolata P. aeruginosa, pod čim se podrazumijeva 
uključivanje drugih molekularnih metoda u otkrivanju potencijalnih odnosa između genetičkih obrazaca i fenotipskih 
obilježja.
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